Top Back to top

Retrospective analysis on the outcome of autologous and allogeneic stem cell transplantation in children and adolescents with non-anaplastic peripheral T-cell lymphoma

Paediatric Diseases Working Party (PDWP)
Study type:
Study number:
Type of Stem Cell Treatment:
Non-Hodgkin’s Lymphoma (NHL)
Short title:
Primary objective:
The primary end points are: Disease-free and overall survival
Secondary end points are: Incidence of relapse, non-relapse mortality; identification of parameters influencing the outcome of stem cell transplantation in pediatric non-anaplastic PTCL
Key inclusion criteria:
- Diagnosis of non-anaplastic peripheral T-cell lymphoma (PTCL) according to the WHO-classification (Campo, Blood 2011), i.e. except of ALK-positive and -negative anaplastic large cell lymphoma (ALCL)
- Age at primary diagnosis of non-anaplastic PTCL < 18 years
- Diagnosis after 1995
- Allogeneic and/or autologous stem cell transplantation
Principal investigator:
Olga Moser
EBMT Study coordinator:
Arnaud Dalissier